Cytokines as potential mediators of acute allograft diastolic dysfunction in cyclosporine-treated patients: a pilot study using in situ hybridization

Transplant Proc. 1994 Oct;26(5):2852-3.

Authors

H Valantine¹, F Johnson, C Dong, N Lewis, D Tovey, P Huie, R Pratt, E Stinson, S Hunt, R Sibley

Affiliation

¹ Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94305-5246.

PMID: 7940898

No abstract available

Publication types

Clinical Trial

MeSH terms

Adult
Biomarkers / analysis
Biopsy, Needle
Cyclosporine / therapeutic use*
Cytokines / biosynthesis*
Diastole*
Drug Therapy, Combination
Female
Heart Transplantation / immunology
Heart Transplantation / pathology
Heart Transplantation / physiology*
Humans
Immunosuppressive Agents / therapeutic use
In Situ Hybridization / methods
Interferon-gamma / biosynthesis
Interleukin-1 / biosynthesis
Interleukin-10 / biosynthesis
Interleukin-2 / biosynthesis
Interleukin-6 / biosynthesis
Male
Middle Aged
Oligonucleotides, Antisense
Pilot Projects
RNA, Messenger / analysis
RNA, Messenger / biosynthesis
Transforming Growth Factor beta / biosynthesis
Transplantation, Homologous
Tumor Necrosis Factor-alpha / biosynthesis

Substances

Biomarkers
Cytokines
Immunosuppressive Agents
Interleukin-1
Interleukin-2
Interleukin-6
Oligonucleotides, Antisense
RNA, Messenger
Transforming Growth Factor beta
Tumor Necrosis Factor-alpha
Interleukin-10
Interferon-gamma
Cyclosporine